Showing results (1051-1060 of 1,134) with videos related to

Sort By:
Pageof 114
International Journal of Environmental Research and Public Health|October 21, 2016
Up-Regulation of Claudin-6 in the Distal Lung Impacts Secondhand Smoke-Induced InflammationJoshua B Lewis, Dallin C Milner, Adam L Lewis, et al.
Journal of Integrative and Complementary Medicine|March 28, 2025
Compendium of Health and Wellness Coaching: 2023 AddendumAbd Moain Abu Dabrh, Jocelyn M Weiss, Bala Munipalli, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 2, 2024
Digital Otoscopy With Computer-Aided Composite Image Generation: Impact on the Correct Diagnosis, Confidence, and TimeSeda Camalan, Carl D Langefeld, Amy Zinnia, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of sulfonamide-pyrazole gamma-secretase inhibitorsMatthew N Mattson, Martin L Neitzel, David A Quincy, et al.
Substance Use & Misuse|April 6, 2012
Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma StudyLesia M Ruglass, Gloria M Miele, Denise A Hien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4M P Reddy, C A Kinney, M A Chaikin, et al.
Journal of Substance Abuse Treatment|March 24, 2010
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?Edward V Nunes, Samuel Ball, Robert Booth, et al.
Pain Medicine (Malden, Mass.)|December 14, 2020
Responding to the Opioid Epidemic: Educational Competencies for Pain and Substance Use Disorder from the Medical Schools of the University of CaliforniaMark Servis, Scott M Fishman, Mark S Wallace, et al.
Blood|August 6, 2009
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)Patrick P Zarrinkar, Ruwanthi N Gunawardane, Merryl D Cramer, et al.
NPJ Schizophrenia|March 18, 2016
Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cellsInkyu S Lee, Claudia M B Carvalho, Panagiotis Douvaras, et al.
Pageof 114